Ullrich N, Bordey A, Gillespie G Y, Sontheimer H
Department of Neurobiology, University of Alabama at Birmingham, 35294, USA.
Neuroscience. 1998 Apr;83(4):1161-73. doi: 10.1016/s0306-4522(97)00456-9.
Using whole-cell patch-clamp recordings, we identified a novel voltage-activated chloride current that was selectively expressed in glioma cells from 23 patient biopsies. Chloride currents were identified in 64% of glioma cells studied in acute slices of nine patient biopsies. These derived from gliomas of various pathological grades. In addition, 98% of cells acutely isolated or in short-term culture from 23 patients diagnosed with gliomas showed chloride current expression. These currents, which we termed glioma chloride currents activated at potentials >45 mV, showed pronounced outward rectification, and were sensitive to bath application of the presumed Cl- channel specific peptide chlorotoxin (approximately 600 nM) derived from Leiurus scorpion venom. Interestingly, low grade tumours (e.g., pilocytic astrocytomas), containing more differentiated, astrocyte-like cells showed expression of glioma chloride currents in concert with voltage-activated sodium and potassium currents also seen in normal astrocytes. By contrast, high grade tumours (e.g., glioblastoma multiforme) expressed almost exclusively chloride currents, suggesting a gradual loss of Na+ currents and gain of Cl- currents with increasing pathological tumour grade. To expand on the observation that these chloride currents are glioma-specific, we introduced experimental tumours in scid mice by intracranial injection of D54MG glioma cells and subsequently recorded from tumour cells and adjacent normal glial cells in acute slices. We consistently observed expression of chlorotoxin-sensitive chloride channels in implanted glioma cells, but without evidence for expression of chloride channels in surrounding "normal" host glial cells, suggesting that these chloride channels are probably a glioma-specific feature. Finding of this novel glioma specific Cl- channel in gliomas in situ and it's selective binding of chlorotoxin may provide a way to identify or target glioma cells in the future.
通过全细胞膜片钳记录,我们鉴定出一种新型的电压激活氯离子电流,该电流在来自23例患者活检组织的胶质瘤细胞中选择性表达。在对9例患者活检组织的急性切片中研究的64%的胶质瘤细胞中鉴定出氯离子电流。这些胶质瘤来源于不同病理分级。此外,从23例诊断为胶质瘤的患者中急性分离或短期培养的细胞中,98%显示出氯离子电流表达。这些电流,我们称之为在电位>45 mV时激活的胶质瘤氯离子电流,表现出明显的外向整流,并且对浴槽中应用的源自Leiurus蝎毒的推测的Cl-通道特异性肽氯毒素(约600 nM)敏感。有趣的是,含有更多分化的星形胶质细胞样细胞的低级别肿瘤(如毛细胞型星形细胞瘤)与正常星形胶质细胞中也可见的电压激活钠电流和钾电流一致地显示出胶质瘤氯离子电流的表达。相比之下,高级别肿瘤(如多形性胶质母细胞瘤)几乎只表达氯离子电流,这表明随着肿瘤病理分级的增加,Na+电流逐渐丧失,Cl-电流增加。为了进一步证实这些氯离子电流是胶质瘤特异性的这一观察结果,我们通过颅内注射D54MG胶质瘤细胞在scid小鼠中引入实验性肿瘤,随后在急性切片中从肿瘤细胞和相邻的正常神经胶质细胞中进行记录。我们始终观察到植入的胶质瘤细胞中氯毒素敏感的氯离子通道的表达,但没有证据表明周围“正常”宿主神经胶质细胞中存在氯离子通道的表达,这表明这些氯离子通道可能是胶质瘤的特异性特征。在原位胶质瘤中发现这种新型的胶质瘤特异性Cl-通道及其对氯毒素的选择性结合可能为未来识别或靶向胶质瘤细胞提供一种方法。